About Bioassay
Bioassay is a company based in Heidelberg (Germany) founded in 2002 was acquired by Reaction Biology in December 2022. The company has 53 employees as of December 31, 2021. Bioassay offers products and services including BioPharma Potency Assays, BioPharma Safety Assessments, Physico-Chemical Analysis, GLP Services, and Veterinary Product Testing. Bioassay operates in a competitive market with competitors including Ribometrix, ReNAgade, Creyon Bio, ArunA Bio and Avilar, among others.
- Headquarter Heidelberg, Germany
- Employees 53 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioassay Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
53
as on Dec 31, 2021
-
Acquired by
Reaction Biology
(Dec 02, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioassay
Bioassay offers a comprehensive portfolio of products and services, including BioPharma Potency Assays, BioPharma Safety Assessments, Physico-Chemical Analysis, GLP Services, and Veterinary Product Testing.
Develop and validate potency assays for biologics under GMP guidelines.
Conduct efficacy and safety studies for biosimilars and APIs.
Perform qualitative and quantitative analysis using HPLC equipment.
Provide toxicity and sensitization studies for compound selection.
Offer GMP potency testing for animal biologics and products.
Funding Insights of Bioassay
Detailed funding history for Bioassay
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Bioassay
Bioassay has secured backing from 1 investor. Prominent investors backing the company include Reaction Biology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
Locked | Locked | Locked |
Investor details for Bioassay
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioassay
Investment portfolio details for Bioassay
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioassay
Detailed financials for Bioassay
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioassay Comparisons
Peer comparison for Bioassay
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioassay
Bioassay operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ribometrix, ReNAgade, Creyon Bio, ArunA Bio and Avilar, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
RNA-targeted drug discovery platform using three-dimensional structural analysis is provided.
|
|
| Locked | Locked | Locked |
RNA-based medicines are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Oligonucleotide-based drug development platform is provided using AI models.
|
|
| Locked | Locked | Locked |
Neural exosome platform is developed for neurodegenerative disease therapeutics.
|
|
| Locked | Locked | Locked |
Drug discovery platform with protein degradation technology is provided.
|
|
| Locked | Locked | Locked |
AI-powered platform for drug discovery
|
Detailed competitors of Bioassay
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioassay
Complete news archive for Bioassay
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioassay
Bioassay was founded in 2002.
Bioassay is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
Sven Michael Cords is the current CEO of Bioassay.
As of Dec 31, 2021, the latest employee count at Bioassay is 53.
Bioassay GmbH was established in 2002 in Heidelberg, Germany, within the biotechnology sector. Biological assays are developed and performed for quality control and product development in pharmaceuticals and chemicals. Emphasis is placed on areas including BioPharma Potency, Efficacy, Safety, and Safety assessments for Chemicals and Cosmetics. Operations adhere to GMP and GLP guidelines, with ISO certification maintained.
Bioassay's top competitors include Ribometrix, Creyon Bio and ArunA Bio.
Bioassay offers BioPharma Potency Assays, BioPharma Safety Assessments, Physico-Chemical Analysis, GLP Services, and Veterinary Product Testing.
Bioassay has 1 investor. Key investors include Reaction Biology.